Urja Global Shareholders Approve Director Appointments, ESOPs, and Fundraise Up to $500M
Urja Global shareholders approved Dr. Anuradha Tomar's appointment as Non-Executive Independent Director and re-appointed Mohan Jagdish Agarwal as MD and Yogesh Kumar Goyal as Whole-Time Director. The company also approved an ESOP scheme with a 56 lakh option pool and a plan to raise up to $500 Million.
The approval of a large fund-raising target of USD 500 Million and key leadership re-appointments are expected to have a significant impact on the company's future operations and growth.
The announcement details several positive corporate actions including director appointments, re-appointments, approval of an ESOP scheme, and a significant fund-raising plan.
Urja Global Limited announced that its shareholders, at the 34th Annual General Meeting held on September 22, 2026, approved several key resolutions. These include the appointment of Dr. Anuradha Tomar as a Non-Executive Independent Director, effective August 05, 2026, and the continuation of Dr. Gopalsetty Prasad Rao as a Non-Executive Independent Director upon attaining the age of 75, effective July 01, 2027.
Furthermore, shareholders re-appointed Mr. Mohan Jagdish Agarwal as Managing Director for a five-year term commencing November 13, 2026, and Mr. Yogesh Kumar Goyal as Whole-Time Director for a five-year term commencing August 05, 2026. The company also received approval for the UGL ESOP Scheme – 2026 “Urja For All,” establishing an option pool of 56,00,000 employee stock options, with provisions for extension to subsidiary companies.
In a significant move, the members approved a proposal to raise funds aggregating up to USD 500 Million through various instruments, including convertible instruments, warrants, and debt instruments, via Qualified Institutional Placement, FCCBs, Rights Issue, FPO, or Private Placement, in one or more tranches.
What to do with a filing like this
Urja Global Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Urja Global Limited. Read the original for the full detail.